105 related articles for article (PubMed ID: 2144926)
1. Selective effect of noncytotoxic blocking alloantibodies produced after platelet transfusions on MLC, and mitogen and soluble antigen-induced responses of human lymphocytes.
Horuzsko A; Gyódi E; Réti M; Mayer K; Kassay M; Petrányi G
Transplantation; 1990 Sep; 50(3):497-501. PubMed ID: 2144926
[TBL] [Abstract][Full Text] [Related]
2. Non-cytotoxic blocking antibodies and suppressor cells induced by donor-specific transfusions in healthy volunteers and potential kidney transplant recipients.
Horuzsko A; Gyódi E; Réti M; Onody K; Perner F; Kassay M; Petrányi GG
Immunol Lett; 1990 Nov; 26(2):127-30. PubMed ID: 2148542
[TBL] [Abstract][Full Text] [Related]
3. Indirect allorecognition of platelets by T helper cells during platelet transfusions correlates with anti-major histocompatibility complex antibody and cytotoxic T lymphocyte formation.
Semple JW; Speck ER; Milev YP; Blanchette V; Freedman J
Blood; 1995 Jul; 86(2):805-12. PubMed ID: 7606011
[TBL] [Abstract][Full Text] [Related]
4. Recipient humoral immunity against leukoreduced allogeneic platelets is suppressed by aminoguanidine, a selective inhibitor of inducible nitric oxide synthase.
Bang A; Speck ER; Blanchette VS; Freedman J; Semple JW
Blood; 1996 Oct; 88(8):2959-66. PubMed ID: 8874192
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of alloimmune reactions induced by leukocyte and platelet transfusions in humans: characteristic changes of activation markers, gamma interferon, and FcR blocking antibody production.
Kotlán B; Gyódi E; Szabó T; Takács K; Troppmair J; Petri I; Padányi A; Kaiser G; Kassai M; Huber C
Hum Immunol; 1988 May; 22(1):19-29. PubMed ID: 3134315
[TBL] [Abstract][Full Text] [Related]
6. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens.
Wilson SE; Habeshaw JA; Addawe MA; Hounsell EF; Oxford JS
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1313-24. PubMed ID: 9339848
[TBL] [Abstract][Full Text] [Related]
7. MLC-inhibiting antibodies in mice after blood transfusions.
Ludwin D; Joseph S; Singal DP
Transplantation; 1986 Jan; 41(1):100-4. PubMed ID: 2934875
[TBL] [Abstract][Full Text] [Related]
8. Role of blood transfusions on the induction of antibodies against recognition sites on T lymphocytes in renal transplant patients.
Singal DP; Joseph S
Hum Immunol; 1982 Apr; 4(2):93-108. PubMed ID: 6210646
[TBL] [Abstract][Full Text] [Related]
9. Unique processing pathways within recipient antigen-presenting cells determine IgG immunity against donor platelet MHC antigens.
Bang KW; Speck ER; Blanchette VS; Freedman J; Semple JW
Blood; 2000 Mar; 95(5):1735-42. PubMed ID: 10688832
[TBL] [Abstract][Full Text] [Related]
10. MLC-inhibiting serum in mice after transfusion with 3 M KCl-extracted soluble antigen.
Ludwin D; Joseph S; Singal DP
J Surg Res; 1987 Nov; 43(5):436-43. PubMed ID: 2446050
[TBL] [Abstract][Full Text] [Related]
11. The polymorphic human TLX-B/CD46/MCP system and its implications in transplantation and reproduction.
Petrányi G; Padányi A; Szelényi J; Sármay G; Gyódi E; Fülöp V; Kassai M; Illés P; Réti M; Szigetvári I
Eur J Immunogenet; 1995 Apr; 22(2):147-61. PubMed ID: 7605772
[TBL] [Abstract][Full Text] [Related]
12. Distinctive functional properties of human blood L lymphocytes: a comparison with T lymphocytes, B lymphocytes, and monocytes.
Horwitz DA; Garrett MA
J Immunol; 1977 May; 118(5):1712-21. PubMed ID: 140193
[TBL] [Abstract][Full Text] [Related]
13. Induction of antibodies by blood transfusions capable of inhibiting responses in MLC.
Nagarkatti PS; Joseph S; Singal DP
Transplantation; 1983 Dec; 36(6):695-9. PubMed ID: 6229073
[TBL] [Abstract][Full Text] [Related]
14. Blood transfusion-induced suppression of cellular immunity in man.
Fischer E; Lenhard V; Seifert P; Kluge A; Johannsen R
Hum Immunol; 1980 Oct; 1(3):187-94. PubMed ID: 6455395
[TBL] [Abstract][Full Text] [Related]
15. Mixed lymphocyte culture (MLC) inhibition in humans due to anti-Ia like (DRW).
Soulillou JP; Naud MF; Peyrat MA; Guenel J
Pathol Biol (Paris); 1978 Dec; 26(9-10):547-51. PubMed ID: 154642
[TBL] [Abstract][Full Text] [Related]
16. Selective activation of antigen-specific human B cells in recently immunized individuals by nonspecific factors in the absence of antigen.
Peters M; Fauci AS
J Immunol; 1983 Feb; 130(2):678-80. PubMed ID: 6184400
[TBL] [Abstract][Full Text] [Related]
17. Specificity of the inhibitory effect of a grand-multipara serum on MLC reactions and on responses to PHA, PWM and PPD.
Herva E; Ilonen J
Acta Pathol Microbiol Scand C; 1977 Dec; 85C(6):424-34. PubMed ID: 75658
[TBL] [Abstract][Full Text] [Related]
18. Functional and immunogenetic characterization of FcR-blocking antibody.
Padányi A; Gyódi E; Sarmay G; Réti M; Mayer K; Kassai M; Petrányi GG
Immunol Lett; 1990 Nov; 26(2):131-7. PubMed ID: 2269483
[TBL] [Abstract][Full Text] [Related]
19. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A
Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
